Acorah Software Products - Accounts Production 19.1.200 false true false true No description of principal activity 24 July 2024 31 July 2025 31 July 2025 15857611 Dr Jyoti Bakshi iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15857611 2024-07-23 15857611 2025-07-31 15857611 2024-07-24 2025-07-31 15857611 frs-core:CurrentFinancialInstruments 2025-07-31 15857611 frs-bus:PrivateLimitedCompanyLtd 2024-07-24 2025-07-31 15857611 frs-bus:FilletedAccounts 2024-07-24 2025-07-31 15857611 frs-bus:Micro-entities 2024-07-24 2025-07-31 15857611 frs-bus:AuditExempt-NoAccountantsReport 2024-07-24 2025-07-31 15857611 frs-bus:Director1 2024-07-24 2025-07-31
Registered number: 15857611
Allwell Rheumatology Ltd
Unaudited Financial Statements
For the Period 24 July 2024 to 31 July 2025
Shaw Wallace
Allwell Rheumatology Ltd
Balance Sheet
As At 31 July 2025
Balance Sheet
Registered number: 15857611

| 31 July 2025
--- | ---
|  | £
Current assets |  | 55,259
Creditors: Amounts Falling Due Within One Year |  | (21,464 )
NET CURRENT ASSETS |  | 33,795
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 33,795
Accruals and deferred income |  | (1,200 )
NET ASSETS |  | 32,595
CAPITAL AND RESERVES |  | 32,595

## Notes

1. General Information
Allwell Rheumatology Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15857611 . The registered office is 43 Manchester Street, London, W1U 7LP.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
Page 0
Page 1
Allwell Rheumatology Ltd
Balance Sheet (continued)
As At 31 July 2025
For the period ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Dr Jyoti Bakshi Director
30/03/2026